Williamson Douglas J 4
4 · AVADEL PHARMACEUTICALS PLC · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Williamson Douglas J
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-14+275,000→ 275,000 totalExercise: $6.60Exp: 2032-02-14→ ADSs (275,000 underlying)
Footnotes (2)
- [F1]Options become exercisable as to 68,750 ADSs on each of the first four anniversaries after the 2/14/2022 grant date.
- [F2]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.